Angiosoma Overview
- Status
- Public
- Employees
- 1

- Stock Symbol
- SOAN

- Investments
- 1
- Share Price
- $0.01
- (As of Wednesday Closing)
Angiosoma General Information
Description
AngioSoma Inc is a US-based is a wellness company. Through its subsidiary, the company is dedicated to bringing innovative, effective, and high-quality supplement products for the medical, wellness, and adult-use markets. Its products comprise OmniCath I and II and Nutraceuticals.
Contact Information
- 14001 Walden Road
- Suite 600
- Montgomery, TX 77356
- United States
Angiosoma Stock Performance
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.01 | $0.01 | $6.42M | 445M | 7.33M |
Angiosoma Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2020 30-Sep-2020 | FY 2019 30-Sep-2019 | FY 2018 30-Sep-2018 |
---|---|---|---|---|
EV | 2,730 | 2,730 | 4,094 | 4,689 |
Revenue | 0 | 0 | 1 | 1 |
EBITDA | (302) | (302) | (314) | (713) |
Net Income | (542) | (542) | (675) | (817) |
Total Assets | 90 | 90 | 142 | 125 |
Total Debt | 215 | 215 | 173 | 345 |
Angiosoma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Angiosoma‘s full profile, request access.
Request a free trialAngiosoma Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Alex Blankenship | President & Chief Executive Officer |
Angiosoma Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAngiosoma Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000 00000 | 07-Jun-2016 | 000000000000000000 | Energy Exploration |